Sign in to view content

Update on Faricimab for DME: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study

Veeral S. Sheth, MD, MBA, FASRS, FACS

Video
Published 2025

Related

Comparability of Diabetic Retinopathy Severity Evaluation on Gold Standard vs Ultra-Widefield Images in YOSEMITE/RHINE Phase 3 Studies
Barbara A. Blodi, MD
Annual Meeting Talks
2025
Population Pharmacokinetics and Safety of OPT-302 an Anti-VEGF-C--D Trap in Patients With Retinal Vascular Diseases
Dante Joseph Pieramici, MD
Annual Meeting Talks
2023
Tarcocimab Tedromer (KSI-301) Anti-VEGF Antibody Biopolymer Conjugate for DME: First-Time Efficacy, Durability and Safety Results of the GLEAM and GLIMMER Phase 3 studies
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more